Deadly, rare lung cancer finds big foe: Patients with little to lose

Posted by ALCF Staff on February 8th, 2017
No Comments

From The San Francisco Business Times:
“Between sessions of the World Lung Cancer Conference in Denver in September 2015, [Lisa] Goldman and another ROS1 patient, Janet Freeman-Daily, had a simple question for ROS1 expert Dr. Ross Camidge of the University of Colorado: What can patients do?”

Read more at the San Francisco Business Times to learn about the work ALCF is doing, at the request of our patients to study the ROS1 gene.

Leave a Reply: